Wendall Wierenga - Net Worth and Insider Trading
Wendall Wierenga Net Worth
The estimated net worth of Wendall Wierenga is at least $2 Million dollars as of 2024-11-13. Wendall Wierenga is the Director of Cytokinetics Inc and owns about 24,559 shares of Cytokinetics Inc (CYTK) stock worth over $1 Million. Wendall Wierenga is the Director of XenoPort Inc and owns about 28,998 shares of XenoPort Inc (XNPT) stock worth over $205,016. Wendall Wierenga is also the Director of Concert Pharmaceuticals Inc and owns about 12,389 shares of Concert Pharmaceuticals Inc (CNCE) stock worth over $103,696. Besides these, Wendall Wierenga also holds Ocera Therapeutics Inc (OCRX) . Details can be seen in Wendall Wierenga's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wendall Wierenga has not made any transactions after 2024-10-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Wendall Wierenga
Wendall Wierenga Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wendall Wierenga owns 8 companies in total, including Crinetics Pharmaceuticals Inc (CRNX) , Cytokinetics Inc (CYTK) , and Concert Pharmaceuticals Inc (CNCE) among others .
Click here to see the complete history of Wendall Wierenga’s form 4 insider trades.
Insider Ownership Summary of Wendall Wierenga
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals Inc | 2018-07-17 | director |
| CYTK | Cytokinetics Inc | 2024-10-28 | director |
| CNCE | Concert Pharmaceuticals Inc | 2018-06-14 | director |
 | | 2014-03-10 | director |
| | 2017-12-11 | director |
| | 2016-07-05 | director |
| | 2016-06-24 | director |
| | 2005-02-18 | EVP & Research & Development |
Wendall Wierenga Latest Holdings Summary
Wendall Wierenga currently owns a total of 4 stocks. Among these stocks, Wendall Wierenga owns 24,559 shares of Cytokinetics Inc (CYTK) as of October 28, 2024, with a value of $1 Million and a weighting of 81.29%. Wendall Wierenga owns 28,998 shares of XenoPort Inc (XNPT) as of May 11, 2015, with a value of $205,016 and a weighting of 12.07%. Wendall Wierenga also owns 12,389 shares of Concert Pharmaceuticals Inc (CNCE) as of March 13, 2014, with a value of $103,696 and a weighting of 6.11%. The other 1 stocks Ocera Therapeutics Inc (OCRX) have a combined weighting of 0.53% among all his current holdings.
Latest Holdings of Wendall Wierenga
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYTK | Cytokinetics Inc | 2024-10-28 | 24,559 | 56.21 | 1,380,339 |
| XNPT | XenoPort Inc | 2015-05-11 | 28,998 | 7.07 | 205,016 |
| CNCE | Concert Pharmaceuticals Inc | 2014-03-13 | 12,389 | 8.37 | 103,696 |
| OCRX | Ocera Therapeutics Inc | 2015-06-23 | 5,000 | 1.79 | 8,950 |
Holding Weightings of Wendall Wierenga
Wendall Wierenga Form 4 Trading Tracker
According to the SEC Form 4 filings, Wendall Wierenga has made a total of 7 transactions in Cytokinetics Inc (CYTK) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Cytokinetics Inc is the sale of 4,452 shares on October 28, 2024, which brought Wendall Wierenga around $232,617.
According to the SEC Form 4 filings, Wendall Wierenga has made a total of 0 transactions in XenoPort Inc (XNPT) over the past 5 years. The most-recent trade in XenoPort Inc is the acquisition of 5,000 shares on May 11, 2015, which cost Wendall Wierenga around $28,150.
According to the SEC Form 4 filings, Wendall Wierenga has made a total of 0 transactions in Concert Pharmaceuticals Inc (CNCE) over the past 5 years. The most-recent trade in Concert Pharmaceuticals Inc is the sale of 0 shares on March 13, 2014, which brought Wendall Wierenga around $0.
More details on Wendall Wierenga's insider transactions can be found in the Insider Trading History of Wendall Wierenga table.Insider Trading History of Wendall Wierenga
- 1
Wendall Wierenga Trading Performance
GuruFocus tracks the stock performance after each of Wendall Wierenga's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wendall Wierenga is 7.48%. GuruFocus also compares Wendall Wierenga's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wendall Wierenga within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wendall Wierenga's insider trading performs compared to the benchmark.
Performance of Wendall Wierenga
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.71 | | | | | |
| Relative Return to S&P 500(%) | 12.14 | | | | | |
Wendall Wierenga Ownership Network
Ownership Network List of Wendall Wierenga
Ownership Network Relation of Wendall Wierenga
Wendall Wierenga Owned Company Details
What does Crinetics Pharmaceuticals Inc do?
Who are the key executives at Crinetics Pharmaceuticals Inc?
Wendall Wierenga is the director of Crinetics Pharmaceuticals Inc. Other key executives at Crinetics Pharmaceuticals Inc include Chief Development Officer Dana Pizzuti , See Remarks Marc Wilson , and Chief Scientific Officer Stephen F. Betz .
Crinetics Pharmaceuticals Inc (CRNX) Insider Trades Summary
Over the past 18 months, Wendall Wierenga made no insider transaction in Crinetics Pharmaceuticals Inc (CRNX). Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 40,035 shares made by Stephen F. Betz , a net sale of 159,049 shares made by Marc Wilson , and a net sale of 91,672 shares made by Dana Pizzuti .
In summary, during the past 3 months, insiders sold 43,410 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 43,410 shares. During the past 18 months, 913,970 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 908,970 shares.
Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Crinetics Pharmaceuticals Inc Insider Transactions
Wendall Wierenga Mailing Address
Above is the net worth, insider trading, and ownership report for Wendall Wierenga. You might contact Wendall Wierenga via mailing address: 12790 El Camino Real, C/o Neurocrine Biosciences, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
